Shuttle Pharmaceuticals Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 14, 2023, by Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation. The filing serves as a current report to announce a corporate update issued via press release in connection with the company's quarterly report on Form 10-Q for the period ended September 30, 2023. The company is classified as an emerging growth company.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a notification of a press release (Exhibit 99.1) rather than a detailed financial statement. Investors must refer to the attached press release or the referenced Form 10-Q for specific financial figures.
Material Changes
The filing does not explicitly detail material changes in financial condition or operations within the text provided. It references a corporate update regarding the third quarter of 2023, but the specific nature of any changes is contained within the attached Exhibit 99.1.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, or risk factors. It notes that the information in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section unless specifically referenced in a subsequent filing.
Key Facts for Investor Verification
- Verify the specific contents of the press release dated November 14, 2023 (Exhibit 99.1), as the 8-K text only references it.
- Review the Form 10-Q for the period ended September 30, 2023, for detailed financial performance metrics.
- Confirm the company's status as an emerging growth company and any implications for financial reporting standards.
- Note that the information in this 8-K is not legally "filed" under Section 18 of the Exchange Act unless incorporated by reference in a future document.